BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 20738795)

  • 1. Hypoglycemia as a result of propranolol during treatment of infantile hemangioma: a case report.
    Breur JM; de Graaf M; Breugem CC; Pasmans SG
    Pediatr Dermatol; 2011; 28(2):169-71. PubMed ID: 20738795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoglycemia in children taking propranolol for the treatment of infantile hemangioma.
    Holland KE; Frieden IJ; Frommelt PC; Mancini AJ; Wyatt D; Drolet BA
    Arch Dermatol; 2010 Jul; 146(7):775-8. PubMed ID: 20644039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Propranolol for infantile hemangiomas.
    Bagazgoitia L; Torrelo A; Gutiérrez JC; Hernández-Martín A; Luna P; Gutiérrez M; Baño A; Tamariz A; Larralde M; Alvarez R; Pardo N; Baselga E
    Pediatr Dermatol; 2011; 28(2):108-14. PubMed ID: 21385205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Propranolol induced hypoglycemia.
    Horev A; Haim A; Zvulunov A
    Pediatr Endocrinol Rev; 2015 Mar; 12(3):308-10. PubMed ID: 25962208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperkalemia complicating propranolol treatment of an infantile hemangioma.
    Pavlakovic H; Kietz S; Lauerer P; Zutt M; Lakomek M
    Pediatrics; 2010 Dec; 126(6):e1589-93. PubMed ID: 21115582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Propranolol for infantile hemangiomas: a preliminary report on efficacy and safety in very low birth weight infants.
    Erbay A; Sarialioglu F; Malbora B; Yildirim SV; Varan B; Tarcan A; Gülcan H; Demir S; Derbent M; Uslu N; Abbasoğlu A
    Turk J Pediatr; 2010; 52(5):450-6. PubMed ID: 21434528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Propranolol for infantile haemangiomas and neuroglycopenic seizures.
    Fusilli G; Merico G; Gurrado R; Rosa T; Acquafredda A; Cavallo L
    Acta Paediatr; 2010 Dec; 99(12):1756. PubMed ID: 20726852
    [No Abstract]   [Full Text] [Related]  

  • 8. β-blockers for infantile hemangiomas: a single-institution experience.
    Blatt J; Morrell DS; Buck S; Zdanski C; Gold S; Stavas J; Powell C; Burkhart CN
    Clin Pediatr (Phila); 2011 Aug; 50(8):757-63. PubMed ID: 21525081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deep coma in a child treated with propranolol for infantile hemangioma.
    Bakalli I; Kola E; Lluka R; Celaj E; Sala D; Gjeta I; Sallabanda S; Klironomi D
    BMC Pediatr; 2019 Jul; 19(1):216. PubMed ID: 31266444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Re: Propranolol treatment for hemangioma of infancy: risks and recommendations.
    Bayliss SJ; Berk DR; Van Hare GF; Balzer D; Yamada K; Lueder G; Lanoel A; de la Fuente V; Cordisco MR
    Pediatr Dermatol; 2010; 27(3):319-20; author reply 320-1. PubMed ID: 20609165
    [No Abstract]   [Full Text] [Related]  

  • 11. Adverse effects of propranolol when used in the treatment of hemangiomas: a case series of 28 infants.
    de Graaf M; Breur JMPJ; Raphaël MF; Vos M; Breugem CC; Pasmans SGMA
    J Am Acad Dermatol; 2011 Aug; 65(2):320-327. PubMed ID: 21601311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic corticosteroid is effective and safe treatment for problematic infantile hemangioma.
    Greene AK
    Pediatr Dermatol; 2010; 27(3):322-3. PubMed ID: 20609168
    [No Abstract]   [Full Text] [Related]  

  • 13. Propranolol, a very promising treatment for ulceration in infantile hemangiomas: a study of 20 cases with matched historical controls.
    Hermans DJ; van Beynum IM; Schultze Kool LJ; van de Kerkhof PC; Wijnen MH; van der Vleuten CJ
    J Am Acad Dermatol; 2011 May; 64(5):833-8. PubMed ID: 21353329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe hypoglycemia during successful treatment of diffuse hemangiomatosis with propranolol.
    Bonifazi E; Acquafredda A; Milano A; Montagna O; Laforgia N
    Pediatr Dermatol; 2010; 27(2):195-6. PubMed ID: 20537072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-dose propranolol for multiple hepatic and cutaneous hemangiomas with deranged liver function.
    Tan ST; Itinteang T; Leadbitter P
    Pediatrics; 2011 Mar; 127(3):e772-6. PubMed ID: 21357335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Response to oral propranolol therapy for ulcerated hemangiomas in infancy].
    Michel JL; Patural H
    Arch Pediatr; 2009 Dec; 16(12):1565-8. PubMed ID: 19892536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Propranolol for infantile haemangiomas: a review.
    Starkey E; Shahidullah H
    Arch Dis Child; 2011 Sep; 96(9):890-3. PubMed ID: 21622997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Propranolol for treatment of ulcerated infantile hemangiomas.
    Saint-Jean M; Léauté-Labrèze C; Mazereeuw-Hautier J; Bodak N; Hamel-Teillac D; Kupfer-Bessaguet I; Lacour JP; Naouri M; Vabres P; Hadj-Rabia S; Nguyen JM; Stalder JF; Barbarot S;
    J Am Acad Dermatol; 2011 May; 64(5):827-32. PubMed ID: 21353332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allergic contact dermatitis caused by topical propranolol in a 5-month-old baby.
    Bonifazi E; Milano A; Foti C
    Contact Dermatitis; 2014 Oct; 71(4):250-1. PubMed ID: 25231389
    [No Abstract]   [Full Text] [Related]  

  • 20. Role of Propranolol in the therapeutic strategy of infantile laryngotracheal hemangioma.
    Denoyelle F; Leboulanger N; Enjolras O; Harris R; Roger G; Garabedian EN
    Int J Pediatr Otorhinolaryngol; 2009 Aug; 73(8):1168-72. PubMed ID: 19481268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.